Cancer patients who don’t respond to immunotherapy lack crucial immune cells
Researchers at Washington University School of Medicine have discovered that the difference between cancer patients who do and do not respond to immunotherapy may have to do with a particular immune cell. The findings could extend the lifesaving benefits of immunotherapy to more patients.
In Africa, hope
Africans have made great strides fighting the legacy of colonialism while contending with the ongoing plunder of their natural resources and geopolitical battles for influence on the continent. Despite this progress, difficulties remain, including poverty, environmental challenges and public health issues.
‘Forum on Medicine, Race and Ethnicity in St. Louis, Past to Future’ Feb. 25
On Feb. 25, the Medical Humanities Program in Arts & Sciences will present the “Forum on Medicine, Race and Ethnicity in St. Louis, Past to Future.” The all-day gathering will feature dozens of speakers and panelists exploring how specific local histories impact the region’s diverse communities.
Computer model IDs roles of individual genes in early embryonic development
Software developed at Washington University School of Medicine can predict what happens to complex gene networks when individual genes are disrupted in specific ways.
Disrupted flow of brain fluid may underlie neurodevelopmental disorders
Researchers at Washington University School of Medicine have discovered that the fluid around the brain flows to areas critical for normal brain development and function, suggesting that disruptions to its circulation may play an underrecognized role in neurodevelopmental disorders.
Needlemans commit $15 million to boost drug discovery
A $15 million commitment from Washington University benefactors Philip and Sima Needleman will enable the university to leverage its expertise in biomedical discovery to boost drug development via the Needleman Program for Innovation and Commercialization.
New diagnostic test is 1,000 times more sensitive than conventional tests
Thinking beyond COVID-19, a team led by Srikanth Singamaneni at the McKelvey School of Engineering developed a new point-of-care diagnostic test that is 1,000 times more sensitive than conventional rapid tests and can quantify concentrations of proteins.
Lananna to study Alzheimer’s-related cognitive decline
Brian Lananna, a postdoctoral research scholar in developmental biology at the School of Medicine, has received a three-year $215,478 postdoctoral fellowship award from the National Institute on Aging of the National Institutes of Health (NIH).
WashU Medicine reaches new heights as it climbs to No. 3 in NIH research funding
Scientists at the Washington University School of Medicine were awarded $569 million in research grants from the National Institutes of Health (NIH) in federal fiscal year 2022, elevating WashU to No. 3 among U.S. medical schools in total NIH research funding support.
Thompson receives National Cancer Institute grant to study cancer patients, caregivers
Tess Thompson, research assistant professor at the Brown School at Washington University in St. Louis, has received a five-year grant from the National Cancer Institute of the National Institutes of Health (NIH) to study unmet social needs of cancer patients and their caregivers, with the ultimate aim of improving outcomes for both.
Older Stories